ORIGINAL RESEARCH article
Front. Cardiovasc. Med.
Sec. Cardiovascular Epidemiology and Prevention
Retrospective Cohort Study Assessing Cardiovascular Risk Reduction Through Intensive Blood Pressure Management in High-Risk Patients
Baihui Tang
Wenxi Gu
Department of Cardiolog,Affiliated Chongming Hospital of Shanghai University of Medicine & Health Sciences, Shanghai, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Abstract
Background: Hypertension remains a major global risk factor for cardiovascular disease. While clinical trials suggest that lower systolic blood pressure (SBP) levels reduce cardiovascular risk, real-world data from high-risk patients remain limited. This study evaluated the association between achieved SBP levels and cardiovascular outcomes in a high-risk hypertensive population. Methods: We performed a retrospective cohort study from January 2022 to December 2024, including 180 high-risk hypertensive patients receiving treatment at a tertiary care facility. Patients were categorized based on achieved systolic blood pressure during follow-up: one group with SBP <120 mmHg and another with SBP between 130–139 mmHg. The primary endpoint was a composite of major adverse cardiovascular events (MACE), including myocardial infarction, stroke, heart failure, and cardiovascular-related death or hospitalization. The secondary outcomes consisted of all-cause mortality and adverse treatment events. Results: Patients in the lower achieved SBP group had significantly fewer MACE events over a median follow-up of 18 months compared with those in the higher SBP group (14.8 vs 26.5, p = 0.03). Treatment was considered to be particularly of benefit for patients with diabetes and chronic kidney disease because the relative risk reduction was 30 % compared to routine control. There was attenuation of benefits in elderly patients, i.e., where age was over 75. Adverse events, including hypotension and renal impairment, were slightly more common in the lower SBP group but remained clinically manageable (9.3 % vs 4.8 %; p = 0.60). Conclusion: Among high-risk hypertensive patients, lower achieved SBP levels were associated with reduced cardiovascular event rates. These findings support the need for further prospective studies to define optimal BP targets, especially in patients with diabetes and chronic kidney disease.
Summary
Keywords
Cardiovascular risk reduction, Chronic Kidney Disease, diabetes, High-risk patients, Hypertension, intensive blood pressure management, Retrospective cohort study
Received
23 September 2025
Accepted
27 January 2026
Copyright
© 2026 Tang and Gu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Wenxi Gu
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.